Cyhoeddiad
2026
- Veiga, S. et al., 2026. Heparan sulphate glycosaminoglycan chains contribute to the tethering of coronal factors and are important for extracellular vesicle‐mediated fibroblast activation. Journal of Extracellular Biology 5 (5) e70146. (10.1002/jex2.70146)
2025
- McCallion, O. et al., 2025. HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model. Nature Communications 16 (1) 9090. (10.1038/s41467-025-64945-3)
2024
- Bliss, C. M. et al. 2024. A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications. Molecular Therapy Advances 32 (3) 101308. (10.1016/j.omtm.2024.101308)
2021
- Evans, L. et al. 2021. Macrophage plasticity and function in the lung tumour microenvironment revealed in 3D heterotypic spheroid and explant models. Biomedicines 9 (3) 302. (10.3390/biomedicines9030302)
2019
- Yamamoto, A. et al., 2019. Systemic silencing of Phd2 causes reversible immune regulatory dysfunction. Journal of Clinical Investigation 129 (9), pp.3640-3656. (10.1172/JCI124099)
- Issa, F. et al., 2019. Transiently activated human regulatory T cells upregulate BCL-XL expression and acquire a functional advantage in vivo. Frontiers in Immunology 10 (10.3389/fimmu.2019.00889)
- Milward, K. , Hester, J. and Wood, K. J. 2019. Isolation of human regulatory T lymphocytes by fluorescence-activated cell sorting. In: Immunological Tolerance. Vol. 1899, Methods in Molecular Biology New York: Humana Press. , pp.43-54. (10.1007/978-1-4939-8938-6_4)
2017
- Milward, K. F. , Wood, K. J. and Hester, J. 2017. Enhancing human regulatory T cells in vitro for cell therapy applications. Immunology Letters 190 , pp.139-147. (10.1016/j.imlet.2017.08.012)
2016
- Milward, K. 2016. Investigation of the cell biology of human regulatory T cells in the context of transplantation. PhD Thesis , University of Oxford.
2013
- Milward, K. et al. 2013. Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells. Transplantation 95 (1), pp.85-93. (10.1097/TP.0b013e31827722ed)
2012
- Issa, F. et al., 2012. Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model. PLoS ONE 7 (12) e53331. (10.1371/journal.pone.0053331)
2011
- Milward, K. et al. 2011. Neuronal and molecular substrates for optimal foraging in Caenorhabditis elegans. Proceedings of the National Academy of Sciences of the United States of America 108 (51), pp.20672-20677. (10.1073/pnas.1106134109)
Articles
- Veiga, S. et al., 2026. Heparan sulphate glycosaminoglycan chains contribute to the tethering of coronal factors and are important for extracellular vesicle‐mediated fibroblast activation. Journal of Extracellular Biology 5 (5) e70146. (10.1002/jex2.70146)
- McCallion, O. et al., 2025. HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model. Nature Communications 16 (1) 9090. (10.1038/s41467-025-64945-3)
- Bliss, C. M. et al. 2024. A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications. Molecular Therapy Advances 32 (3) 101308. (10.1016/j.omtm.2024.101308)
- Evans, L. et al. 2021. Macrophage plasticity and function in the lung tumour microenvironment revealed in 3D heterotypic spheroid and explant models. Biomedicines 9 (3) 302. (10.3390/biomedicines9030302)
- Yamamoto, A. et al., 2019. Systemic silencing of Phd2 causes reversible immune regulatory dysfunction. Journal of Clinical Investigation 129 (9), pp.3640-3656. (10.1172/JCI124099)
- Issa, F. et al., 2019. Transiently activated human regulatory T cells upregulate BCL-XL expression and acquire a functional advantage in vivo. Frontiers in Immunology 10 (10.3389/fimmu.2019.00889)
- Milward, K. F. , Wood, K. J. and Hester, J. 2017. Enhancing human regulatory T cells in vitro for cell therapy applications. Immunology Letters 190 , pp.139-147. (10.1016/j.imlet.2017.08.012)
- Milward, K. et al. 2013. Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells. Transplantation 95 (1), pp.85-93. (10.1097/TP.0b013e31827722ed)
- Issa, F. et al., 2012. Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model. PLoS ONE 7 (12) e53331. (10.1371/journal.pone.0053331)
- Milward, K. et al. 2011. Neuronal and molecular substrates for optimal foraging in Caenorhabditis elegans. Proceedings of the National Academy of Sciences of the United States of America 108 (51), pp.20672-20677. (10.1073/pnas.1106134109)
Book sections
- Milward, K. , Hester, J. and Wood, K. J. 2019. Isolation of human regulatory T lymphocytes by fluorescence-activated cell sorting. In: Immunological Tolerance. Vol. 1899, Methods in Molecular Biology New York: Humana Press. , pp.43-54. (10.1007/978-1-4939-8938-6_4)
Thesis
- Milward, K. 2016. Investigation of the cell biology of human regulatory T cells in the context of transplantation. PhD Thesis , University of Oxford.
Contact Details
[email protected]
Adeilad Geneteg Canser, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4XN
Adeilad Geneteg Canser, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4XN
Themâu ymchwil
Arbenigeddau
- Imiwnoleg canser
- Imiwnoleg cellog